CLIMB BIO INC. - COMMON STOCK
3,0500
22-ноября-24 16:44:58
15 мин. задержка
Акции
+0,0500
+1,67%
Сегодняшний диапазон
3,0150 - 3,3000
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights
12 ноя 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board
11 ноя 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Climb Bio to Present at Upcoming Investor Conferences
31 окт 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event
15 окт 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
11 окт 2024 12:30:00 Источник Nasdaq GlobeNewswire
-
04 окт 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Climb Bio to Host Virtual Investor Event on October 15, 2024
03 окт 2024 10:00:16 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.
02 окт 2024 09:00:23 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit
11 сен 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics Announces Additions to its Leadership Team
26 авг 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports Second Quarter Financial Results
14 авг 2024 06:05:00 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
28 июн 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
27 июн 2024 16:01:00 Источник Nasdaq GlobeNewswire
-
11 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics Announces Plans to Explore Strategic Alternatives
20 июл 2023 06:45:00 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights
11 май 2023 16:10:00 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights
06 мар 2023 16:10:00 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics Provides Strategic Update and Announces Leadership Transition
09 фев 2023 16:01:00 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual Conference
30 ноя 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Eliem Therapeutics Reports Third Quarter Financial and Business Highlights
14 ноя 2022 06:10:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >